Literature DB >> 35430669

Correction to: Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis.

Lan-Qing Yao1, Zheng-Liang Chen2, Zi-Han Feng3, Yong-Kang Diao4, Chao Li1, Hai-Ying Sun1, Jian-Hong Zhong5, Ting-Hao Chen6, Wei-Min Gu7, Ya-Hao Zhou8, Wan-Guang Zhang9, Hong Wang10, Yong-Yi Zeng11, Han Wu1, Ming-Da Wang1, Xin-Fei Xu1, Timothy M Pawlik12, Wan Yee Lau1,13, Feng Shen14, Tian Yang15,16.   

Abstract

Entities:  

Year:  2022        PMID: 35430669     DOI: 10.1245/s10434-022-11790-z

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  1 in total

1.  Hepatocellular Carcinoma Recurrence Risk in the Context of Emerging Therapies.

Authors:  Mark A Healy; Michael A Choti
Journal:  Ann Surg Oncol       Date:  2022-05-05       Impact factor: 5.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.